To include your compound in the COVID-19 Resource Center, submit it here.

Astellas, Royalty Pharma deal

Astellas sold its dipeptidyl peptidase-4 (DPP-4) patent estate and royalty stream

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE